article thumbnail

Coronary Sinus Narrowing Improves Coronary Microcirculation Function in Patients With Refractory Angina: A Multicenter Prospective INROAD Study

Circulation: Cardiovascular Interventions

Circulation: Cardiovascular Interventions, Volume 17, Issue 1 , Page e013481, January 1, 2024. Seattle Angina Questionnaire summary score increase of around 3 points (3.01 [95% CI, 1.39–4.61]).CONCLUSIONS:Coronary The primary outcome was the change in the values of the index of microcirculatory resistance.

Angina 40
article thumbnail

Optimal Predilatation Treatment Before Implantation of a Magmaris Bioresorbable Scaffold in Coronary Artery Stenosis: The OPTIMIS Trial

Circulation: Cardiovascular Interventions

Circulation: Cardiovascular Interventions, Volume 18, Issue 1 , Page e014665, January 1, 2025. BACKGROUND:Bioresorbable scaffolds (BRS) were developed to overcome limitations related to late stent failures of drug-eluting stents, but lumen reductions over time after implantation of BRS have been reported. versus 6.31.5 versus 7.51.7

article thumbnail

Characterising Mechanisms of Ischemia in Patients with Myocardial Bridges

Circulation: Cardiovascular Interventions

Circulation: Cardiovascular Interventions, Ahead of Print. Background:Myocardial bridges (MBs) are prevalent and can be associated with acute and chronic ischemic syndromes.

article thumbnail

"A patient just arrived as a transfer for NSTEMI."

Dr. Smith's ECG Blog

Circulation: Cardiovascular Interventions , 7(5), 645–655. Serial EKG is very high yield diagnostic test in patients with stuttering angina. Starovoytov, A., Robinson, S., Vuurmans, T., Humphries, K., & & Mancini, G. Spontaneous coronary artery dissection.

SCAD 123
article thumbnail

Johnson and Johnson to Acquire Shockwave Medical

DAIC

The acquisition of Shockwave further extends Johnson & Johnson MedTech’s position in cardiovascular intervention and accelerates its shift into higher-growth markets. Cardiovascular intervention is one of the fastest-growing global medtech markets, with significant unmet patient need.

article thumbnail

Why Indications for CTO- PCI are still tentative and vague ?

Dr. S. Venkatesan MD

Most studies looked only at angina as a symptom.Very few included patients with dyspnea as a symptom. If symptoms are angina and it is refractory, one may consider CTO PCI. DECISON CTO Of the above four, only the DECSION -CTO was negative, still many cardiologists are not ok to do a CTO PCI. The reason is simple. EuroIntervention.

Angina 52
article thumbnail

What Cardiometabolic Clinicians Can Be Thankful For This Year

Cardiometabolic Health Congress

Advancements in Cardiovascular Interventions and Clinical Guidelines 2024 ESC Guidelines for Chronic Coronary Syndromes : Updated guidelines from the European Society of Cardiology (ESC) emphasized shortened dual antiplatelet therapy (DAPT) durations and the potential for P2Y12 inhibitor monotherapy after percutaneous coronary intervention (PCI).